These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

951 related items for PubMed ID: 28859944

  • 21. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
    Bakris GL, Townsend RR, Flack JM, Brar S, Cohen SA, D'Agostino R, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL, SYMPLICITY HTN-3 Investigators.
    J Am Coll Cardiol; 2015 Apr 07; 65(13):1314-1321. PubMed ID: 25835443
    [Abstract] [Full Text] [Related]

  • 22. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.
    Voora R, Hinderliter AL.
    Curr Hypertens Rep; 2018 Sep 07; 20(11):92. PubMed ID: 30194545
    [Abstract] [Full Text] [Related]

  • 23. Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial.
    Weber MA, Schmieder RE, Kandzari DE, Townsend RR, Mahfoud F, Tsioufis K, Kario K, Pocock S, Tatakis F, Ewen S, Choi JW, East C, Lee DP, Ma A, Cohen DL, Wilensky R, Devireddy CM, Lea JP, Schmid A, Fahy M, Böhm M.
    Clin Res Cardiol; 2022 Nov 07; 111(11):1269-1275. PubMed ID: 35852582
    [Abstract] [Full Text] [Related]

  • 24. Transurethral Renal Pelvic Denervation: A Feasibility Trial in Patients with Uncontrolled Hypertension.
    Hering D, Nikoleishvili D, Imedadze A, Dughashvili G, Klimiashvili Z, Bekaia E, Shengelia T, Kobalava M, Goguadze O, Emukhvari T, Druker V, Sackner-Bernstein J, Weber MA.
    Hypertension; 2022 Dec 07; 79(12):2787-2795. PubMed ID: 36254733
    [Abstract] [Full Text] [Related]

  • 25. Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation.
    Mahfoud F, Townsend RR, Kandzari DE, Kario K, Schmieder RE, Tsioufis K, Pocock S, David S, Patel K, Rao A, Walton A, Bloom JE, Weber T, Suppan M, Lauder L, Cohen SA, McKenna P, Fahy M, Böhm M, Weber MA.
    J Am Coll Cardiol; 2021 Jun 15; 77(23):2909-2919. PubMed ID: 33957242
    [Abstract] [Full Text] [Related]

  • 26. 12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation.
    Azizi M, Daemen J, Lobo MD, Mahfoud F, Sharp ASP, Schmieder RE, Wang Y, Saxena M, Lurz P, Sayer J, Bloch MJ, Basile J, Weber MA, Rump LC, Levy T, Sapoval M, Sanghvi K, Rader F, Fisher NDL, Gosse P, Abraham J, Claude L, Barman NC, McClure CK, Liu Y, Kirtane AJ, RADIANCE-HTN Investigators.
    JACC Cardiovasc Interv; 2020 Dec 28; 13(24):2922-2933. PubMed ID: 33357531
    [Abstract] [Full Text] [Related]

  • 27. Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial.
    Kario K, Mahfoud F, Kandzari DE, Townsend RR, Weber MA, Schmieder RE, Tsioufis K, Pocock S, Brar S, Hettrick DA, Fahy M, Böhm M.
    Hypertens Res; 2023 Jan 28; 46(1):280-288. PubMed ID: 36241705
    [Abstract] [Full Text] [Related]

  • 28. The effect of renal denervation on resistant hypertension: Meta-analysis of randomized controlled clinical trials.
    Yao Y, Zhang D, Qian J, Deng S, Huang Y, Huang J.
    Clin Exp Hypertens; 2016 Jan 28; 38(3):278-86. PubMed ID: 27018652
    [Abstract] [Full Text] [Related]

  • 29. The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications.
    Kandzari DE, Kario K, Mahfoud F, Cohen SA, Pilcher G, Pocock S, Townsend R, Weber MA, Böhm M.
    Am Heart J; 2016 Jan 28; 171(1):82-91. PubMed ID: 26699604
    [Abstract] [Full Text] [Related]

  • 30. Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence.
    Weber MA, Mahfoud F, Schmieder RE, Kandzari DE, Tsioufis KP, Townsend RR, Kario K, Böhm M, Sharp ASP, Davies JE, Osborn JW, Fink GD, Euler DE, Cohen DL, Schlaich MP, Esler MD.
    JACC Cardiovasc Interv; 2019 Jun 24; 12(12):1095-1105. PubMed ID: 31221299
    [Abstract] [Full Text] [Related]

  • 31. Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the OneShotTM ablation system (RAPID) study.
    Verheye S, Ormiston J, Bergmann MW, Sievert H, Schwindt A, Werner N, Vogel B, Colombo A.
    EuroIntervention; 2015 Feb 24; 10(10):1221-9. PubMed ID: 25452198
    [Abstract] [Full Text] [Related]

  • 32. Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial.
    Azizi M, Mahfoud F, Weber MA, Sharp ASP, Schmieder RE, Lurz P, Lobo MD, Fisher NDL, Daemen J, Bloch MJ, Basile J, Sanghvi K, Saxena M, Gosse P, Jenkins JS, Levy T, Persu A, Kably B, Claude L, Reeve-Stoffer H, McClure C, Kirtane AJ, RADIANCE-HTN Investigators.
    JAMA Cardiol; 2022 Dec 01; 7(12):1244-1252. PubMed ID: 36350593
    [Abstract] [Full Text] [Related]

  • 33. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
    Bakris GL, Townsend RR, Liu M, Cohen SA, D'Agostino R, Flack JM, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL, SYMPLICITY HTN-3 Investigators.
    J Am Coll Cardiol; 2014 Sep 16; 64(11):1071-8. PubMed ID: 24858423
    [Abstract] [Full Text] [Related]

  • 34. Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials.
    Kirtane AJ, Sharp ASP, Mahfoud F, Fisher NDL, Schmieder RE, Daemen J, Lobo MD, Lurz P, Basile J, Bloch MJ, Weber MA, Saxena M, Wang Y, Sanghvi K, Jenkins JS, Devireddy C, Rader F, Gosse P, Sapoval M, Barman NC, Claude L, Augustin D, Thackeray L, Mullin CM, Azizi M, RADIANCE Investigators and Collaborators.
    JAMA Cardiol; 2023 May 01; 8(5):464-473. PubMed ID: 36853627
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial.
    Wang J, Yin Y, Lu C, Lu Z, Hu J, Wang Y, Ge J, Jiang H, Yao C, Yan X, Ma W, Qi X, Dang Y, Chen S, Zhu J, Wang D, Ding C, Wang W, Liu J, Wang Y, Li H, Pan Z, Cui K, Li C, Liang X, Chen W, Sobotka PA, Zhang J, Esler M, Sun N, Chen M, Huo Y.
    EClinicalMedicine; 2024 Jun 01; 72():102626. PubMed ID: 38756107
    [Abstract] [Full Text] [Related]

  • 36. SYMPLICITY HTN-Japan - First Randomized Controlled Trial of Catheter-Based Renal Denervation in Asian Patients - .
    Kario K, Ogawa H, Okumura K, Okura T, Saito S, Ueno T, Haskin R, Negoita M, Shimada K, SYMPLICITY HTN-Japan Investigators.
    Circ J; 2015 Jun 01; 79(6):1222-9. PubMed ID: 25912693
    [Abstract] [Full Text] [Related]

  • 37. Randomized Trials of Renal Denervation for Uncontrolled Hypertension: An Updated Meta-Analysis.
    Mufarrih SH, Qureshi NQ, Khan MS, Kazimuddin M, Secemsky E, Bloch MJ, Giri J, Cohen D, Swaminathan RV, Feldman DN, Alaswad K, Kirtane A, Kandzari D, Aronow HD.
    J Am Heart Assoc; 2024 Aug 20; 13(16):e034910. PubMed ID: 39140334
    [Abstract] [Full Text] [Related]

  • 38. Ambulatory Blood Pressure Monitoring to Predict Response to Renal Denervation: A Post Hoc Analysis of the RADIANCE-HTN SOLO Study.
    Gosse P, Cremer A, Kirtane AJ, Lobo MD, Saxena M, Daemen J, Wang Y, Stegbauer J, Weber MA, Abraham J, Kario K, Bangalore S, Claude L, Liu Y, Azizi M.
    Hypertension; 2021 Feb 20; 77(2):529-536. PubMed ID: 33356403
    [Abstract] [Full Text] [Related]

  • 39. A controlled trial of renal denervation for resistant hypertension.
    Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL, SYMPLICITY HTN-3 Investigators.
    N Engl J Med; 2014 Apr 10; 370(15):1393-401. PubMed ID: 24678939
    [Abstract] [Full Text] [Related]

  • 40. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
    Mauri L, Kario K, Basile J, Daemen J, Davies J, Kirtane AJ, Mahfoud F, Schmieder RE, Weber M, Nanto S, Azizi M.
    Am Heart J; 2018 Jan 10; 195():115-129. PubMed ID: 29224639
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.